Shilpa Medicare gets Korean FDA approval for gemcitabine, ambroxol HCl
Wednesday, January 16, 2008 16:00 IST Our Bureau, Mumbai
Shilpa Medicare Ltd has submitted its DMF's for Ambroxol HCL and Gemcitabine HCL to South Korean FDA in 2007 and the South Korea FDA (KFDA) officials inspected the company's manufacturing facilities in last week of Nov. 2007.
